Afyx Development A/S: Financial statements 2020
CVR: 35839739
Afyx Development A/S (CVR 35839739) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -36,231,067 and a net result of DKK -49,478,597 compared with DKK -57,736,809 the year before. Equity amounted to DKK -52,983,883. The company had 10 employees in the financial year.
- Gross Profit
- -36,231,067 kr.
- Profit/Loss
- -49,478,597 kr.
- Equity
- -52,983,883 kr.
- Total Assets
- 47,819,013 kr.
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -36.2 mio. | -49.5 mio. | -53 mio. | 10 |
| 2019 | - | -52.5 mio. | -57.7 mio. | -3.5 mio. | 10 |
| 2018 | - | -37.6 mio. | -45.1 mio. | 54.2 mio. | 8 |
| 2017 | - | -23.4 mio. | -25.6 mio. | 99.3 mio. | 3 |
| 2016 | - | -10.1 mio. | -9.3 mio. | 6.4 mio. | 1 |
How creditworthy is Afyx Development A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Afyx Development A/S has published its annual report for 2019. Gross profit came to DKK -52,476,166, and the net result was DKK -57,736,809.
As of May 20, 2020, Nishan de Silva has joined the board of directors of Afyx Development A/S.
About Afyx Development A/S
Afyx Development A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Juan Møller-San Pedro. The company is owned by Afyx Therapeutics A/S. The company has 8 employees. In 2025, the company reported a gross profit of DKK -5,044,782 and a net result of DKK -4,260,251 compared with DKK -6,896,490 the year before. Equity amounted to DKK -7,253,987.
